8 articles
Delhi High Court clarifies that no pre-grant notice is required under Section 43 and divisional applications must be filed before patent grant.
Calcutta High Court upholds Pharmacyclics divisional patent application for ibrutinib-anti-CD20 therapy, interpreting Section 16 of the Patents Act, 1970.
The Delhi High Court upheld the validity of Novartis’s Ceritinib patent against Natco’s challenge, addressing divisional application issues and allegations of suppression. The injunction against Natco remains in…
The Delhi High Court has reiterated the need for transparency in patent refusal orders, stating that clear grounds must be provided. The judgment highlights the importance of detailed…
The Delhi High Court has stressed the necessity for detailed reasoning in patent refusal decisions. In this case, the absence of specific analysis and clarity in rejecting a…
The Delhi High Court has clarified that divisional applications under the Patents Act must not exceed the scope of the parent application and require plurality of inventions in…
This post offers a detailed analysis of the various types of patent applications as recognised by Indian law. It explains their respective legal requirements, timelines, and procedural distinctions…
This post describes the different types of patent applications available under Indian law and their essential procedural requirements. It provides clarity on the patent process in India, focusing…